EGFR-IN-186
EGFR-IN-186 is a potent inhibitor of EGFR with an IC50 of 0.065 µM. EGFR-IN-186 also exhibits inhibitory activity against EGFRL858R (IC50 = 0.528 µM) and EGFRT790M (IC50 = 0.465 µM). EGFR-IN-186 induces apoptosis by increasing Bax and caspase-3 levels and down-regulating Bcl-2 expression level. EGFR-IN-186 can be used for the research of non-small cell lung cancer (NSCLC).
For research use only. We do not sell to patients.
- Formula: C24H20N6O3S
- Molecular Weight:472.52
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
EGFR 0.065 μM (IC50) |
EGFRL858R 0.528 μM (IC50) |
EGFRT790M 0.465 μM (IC50) |
In Vitro
EGFR-IN-186 (compound 6) (48 h) exhibits potent cytotoxicity against A549, NCI-H460, and HOP-62 cancer cell lines (IC50 = 4.55, 26.09, and 10.72 μM, respectively), while showing significantly lower toxicity toward the normal human lung fibroblast cell line WI-38 (IC50 = 44.64 μM)[1].
EGFR-IN-186 (48 h) exhibits enhancement in its cytotoxicity against A-549 cells (IC50 = 2.38 μM after radiation), indicating that it shows a good radiosensitizing ability[1].
EGFR-IN-186 (4.55 μM; 48 h) induces apoptosis through increasing Bax and caspase-3 levels and down-regulating Bcl-2 expression level in A549 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:A-549
-
Concentration:4.55 μM
-
Incubation Time:48 h
-
Result:Caused a remarkable increase in early apoptosis from 0.79% (control) to 18.51%.
Showed an increase in the late cellular apoptosis from 0.18% (control) to 6.57%.
Induced early apoptosis in A-549 cells 1.65 folds better than Erlotinib (HY-50896).
-
Cell Line:A-549
-
Concentration:4.55 μM
-
Incubation Time:48 h
-
Result:Increased the level of pro-apoptotic protein Bax expression compared to control.
Down-regulated the level of the expression of anti-apoptotic protein Bcl-2 compared to control.
Increased the Bax/BCl-2 ratio.
Led to activation of caspase-3 and increased its expression level when compared to untreated control cells.
Chemical Information
-
Molecular Weight 472.52
-
Formula C24H20N6O3S
-
SMILES
O=C(NC=N1)C2=C1N(C=C2C3=CC=CC=C3)C4=CC=C(S(=O)(NC5=NC(C)=CC(C)=N5)=O)C=C4
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)